Attacking the supply wagons to starve cancer cells to death
Open Access
- 3 March 2016
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 590 (7) , 885-907
Abstract
The constitutive anabolism of cancer cells not only supports proliferation but also addicts tumor cells to a steady influx of exogenous nutrients. Limiting access to metabolic substrates could be an effective and selective means to block cancer growth. In this review, we define the pathways by which cancer cells acquire the raw materials for anabolism, highlight the actionable proteins in each pathway, and discuss the status of therapeutic interventions that disrupt nutrient acquisition. Critical open questions to be answered before apical metabolic inhibitors can be successfully and safely deployed in the clinic are also outlined. In summary, recent studies provide strong support that substrate limitation is a powerful therapeutic strategy to effectively, and safely, starve cancer cells to death.Keywords
Funding Information
- National Institutes of Health (R01 GM089919, R21 CA178230)
- Congressionally Directed Medical Research Programs (W81XWH‐15‐1‐0010)
- American Cancer Society (RSG‐11‐111‐01‐CDD)
- National Cancer Institute (T32CA009054)
This publication has 229 references indexed in Scilit:
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cellsNature, 2013
- A Competitive Nucleotide Binding Inhibitor: In Vitro Characterization of Rab7 GTPase InhibitionACS Chemical Biology, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic StateCell, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEBThe EMBO Journal, 2012
- Inhibition of the PtdIns(5) kinase PIKfyve disrupts intracellular replication of SalmonellaThe EMBO Journal, 2010
- Calorie restriction and cancer prevention: metabolic and molecular mechanismsTrends in Pharmacological Sciences, 2010
- Tumours with PI3K activation are resistant to dietary restrictionNature, 2009
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase ActivityCancer Cell, 2008